1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Hirashima, Y; Ikeda, H; Karasawa, K; Kurimoto, M; Sato, N; Setaka, M; Takaku, A; Yokoyama, K | 1 |
| Palmer, C; Roberts, RL; Viswanath, M | 1 |
| DeMello, D; Lagunoff, D; Ohar, JA; Waller, KS | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atrophy
| Article | Year |
|---|---|
Deficient platelet-activating factor and related enzymes in hemimegalencephaly.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Atrophy; Epilepsy, Generalized; Female; Humans; Infant; Magnetic Resonance Imaging; Occipital Lobe; Phospholipases A; Platelet Activating Factor; Psychosurgery; Rabbits; Recurrence; Reoperation; Transferases (Other Substituted Phosphate Groups) | 1999 |
Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection.
Topics: Animals; Animals, Newborn; Atrophy; Azepines; Brain; Brain Edema; Female; Hypoxia-Ischemia, Brain; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Triazoles; Weight Gain | 2000 |
Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits.
Topics: Animals; Atrophy; Cardiomegaly; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Platelet Activating Factor; Pulmonary Artery; Rabbits | 1991 |